COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,620 Articles (22,913 medRxiv, 8,707 bioRxiv)

Most recent first Previous |  Page 731: Articles 7301-7310  | Next

Prospective investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic
Thon, V., Piler, P., Pavlik, T., Andryskova, L., Dolezel, K., Kostka, D., Pikhart, H., Bobak, M., Klanova, J.
10.1101/2022.07.21.22277881 — Posted: 2022-07-22
Effect of COVID-19 vaccine on long-COVID: A 2-year follow-up observational study from hospitals in north India
Budhiraja, S., INDRAYAN, A., MAHAJAN, M.
10.1101/2022.07.18.22277740 — Posted: 2022-07-22
Evaluation of trace elements analysis in Pediatric Patients with COVID-19：A report from Turkey
Dalkiran, T., Unsal, V., Ipek, S., Oncu, D., Mercan, M., Kandur, Y.
10.1101/2022.07.20.22277852 — Posted: 2022-07-22
A distinct symptom pattern emerges for COVID-19 Long-Haul: A nationwide study
Downs, C. A., Pinto, M. D., Huang, Y., Corps, S., El-Azab, S. A., Ramrakhiani, N. S., Barisano, A., Yu, L., Taylor, K., Esperancas, A., Abrahim, H., Hughes, T. D., Giraldo Herrera, M., Rahmani, A., Dutt, N., Chakraborty, R., Mendiola, C., Lambert, N. J.
10.1101/2022.07.21.22277910 — Posted: 2022-07-22
The Effect of SARS-COV-2 Variant on Respiratory Features and Mortality Among Vaccinated and Non-Fully Vaccinated Patients
Hughes, T. D., Subramanian, A., Chakraborty, R., Cotton, S. A., Herrera, M. D. P. G., Huang, Y., Lambert, N., Pinto, M. D., Rahmani, A. M., Sierra, C. J., Downs, C. A.
10.1101/2022.07.21.22277907 — Posted: 2022-07-22
Characterizing spatiotemporal trends in self-reported mask-wearing behavior in the United States
Taube, J. C., Susswein, Z., Bansal, S.
10.1101/2022.07.19.22277821 — Posted: 2022-07-22
Buying time: detecting VOCs in SARS-CoV-2 via co-evolutionary signals
Barrett, C., Bura, A. C., He, Q., Huang, F. W., Li, T. J. X., Reidys, C. M.
10.1101/2022.07.21.500897 — Posted: 2022-07-21
Temporal profiling of CD4 T-cell activation and differentiation upon SARS-CoV-2 spike protein immunisation
Almeida-Santos, J., Berkachy, R., Tye, C. A., Hassan, J., Kalfaoglu, B., Selkirk, M. E., Ono, M.
10.1101/2022.07.21.500987 — Posted: 2022-07-21
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol
Forshaw, D., Wall, E. C., Prescott, G., Dehbi, H.-M., Green, A., Attree, E., Hismeh, L., Strain, W. D., Crooks, M. G., Watkins, C., Robson, C., Banerjee, R., Lorgelly, P., Heightman, M., Banerjee, A., the STIMULATE-ICP trial team
10.1101/2022.07.21.22277893 — Posted: 2022-07-21
Geographic and Temporal Patterns in Covid-19 Mortality by Race and Ethnicity in the United States from March 2020 to February 2022
Lundberg, D. J., Cho, A., Raquib, R. V., Nsoesie, E. O., Wrigley-Field, E., Stokes, A. C.
10.1101/2022.07.20.22277872 — Posted: 2022-07-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).